Godsey & Gibb Associates Stryker Corp Transaction History

Godsey & Gibb Associates

$977 Million
Q4 2024

A detailed history of Godsey & Gibb Associates transactions in Stryker Corp stock. As of the latest transaction made, Godsey & Gibb Associates holds 66,536 shares of SYK stock, worth $26.2 Million. This represents 2.45% of its overall portfolio holdings.

Number of Shares

66,536

Previous 67,260 1.08%

Holding current value

$26.2 Million

Previous $24.3 Million 1.39%

% of portfolio

2.45%

Previous 2.33%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 14, 2025	SELL	$345.14 - $392.15 $249,881 - $283,916	-724 Reduced 1.08%	66,536 $24 Million
Q3 2024 Oct 18, 2024	BUY	$315.94 - $371.96 $127,007 - $149,527	402 Added 0.6%	67,260 $24.3 Million
Q2 2024 Jul 23, 2024	SELL	$324.3 - $354.67 $320,732 - $350,768	-989 Reduced 1.46%	66,858 $22.7 Million
Q1 2024 Apr 23, 2024	SELL	$293.94 - $358.71 $1.04 Million - $1.26 Million	-3,526 Reduced 4.94%	67,847 $24.3 Million
Q4 2023 Jan 16, 2024	SELL	$253.85 - $299.46 $210,695 - $248,551	-830 Reduced 1.15%	71,373 $21.4 Million
Q3 2023 Oct 25, 2023	SELL	$266.54 - $302.43 $452,051 - $512,921	-1,696 Reduced 2.3%	72,203 $19.7 Million
Q2 2023 Jul 25, 2023	SELL	$271.49 - $305.09 $773,746 - $869,506	-2,850 Reduced 3.71%	73,899 $22.5 Million
Q1 2023 Apr 18, 2023	SELL	$246.13 - $285.47 $729,283 - $845,847	-2,963 Reduced 3.72%	76,749 $21.9 Million
Q4 2022 Jan 18, 2023	SELL	$205.51 - $253.93 $370,945 - $458,343	-1,805 Reduced 2.21%	79,712 $0
Q3 2022 Oct 24, 2022	BUY	$189.27 - $231.83 $15.4 Million - $18.9 Million	81,517 New	81,517 $16.5 Million
Q4 2021 Feb 15, 2022	SELL	$236.63 - $276.44 $19.2 Million - $22.4 Million	-81,131 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$248.9 - $280.09 $207,084 - $233,034	-832 Reduced 1.02%	81,131 $21.4 Million
Q2 2021 Aug 05, 2021	SELL	$242.95 - $267.0 $470,108 - $516,645	-1,935 Reduced 2.31%	81,963 $21.3 Million
Q1 2021 May 14, 2021	BUY	$221.01 - $248.82 $18.5 Million - $20.9 Million	83,898 New	83,898 $20.4 Million
Q1 2021 May 13, 2021	SELL	$221.01 - $248.82 $17.9 Million - $20.2 Million	-81,191 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$202.01 - $245.04 $1,414 - $1,715	-7 Reduced 0.01%	81,191 $19.9 Million
Q3 2020 Nov 10, 2020	BUY	$177.77 - $215.81 $330,652 - $401,406	1,860 Added 2.34%	81,198 $16.9 Million
Q2 2020 Aug 12, 2020	BUY	$144.67 - $207.03 $168,540 - $241,189	1,165 Added 1.49%	79,338 $14.3 Million
Q1 2020 May 11, 2020	SELL	$126.5 - $225.1 $168,371 - $299,608	-1,331 Reduced 1.67%	78,173 $13 Million
Q4 2019 Feb 06, 2020	BUY	$197.98 - $220.53 $828,942 - $923,359	4,187 Added 5.56%	79,504 $16.7 Million
Q3 2019 Nov 13, 2019	SELL	$205.4 - $221.82 $3.04 Million - $3.29 Million	-14,822 Reduced 16.44%	75,317 $16.3 Million
Q2 2019 Aug 07, 2019	BUY	$180.24 - $205.58 $289,285 - $329,955	1,605 Added 1.81%	90,139 $18.5 Million
Q1 2019 May 14, 2019	BUY	$152.46 - $198.0 $61,746 - $80,190	405 Added 0.46%	88,534 $17.5 Million
Q4 2018 Feb 13, 2019	BUY	$145.0 - $178.65 $1.09 Million - $1.34 Million	7,512 Added 9.32%	88,129 $13.8 Million
Q3 2018 Nov 13, 2018	SELL	$163.25 - $177.68 $210,755 - $229,384	-1,291 Reduced 1.58%	80,617 $14.3 Million
Q2 2018 Aug 14, 2018	SELL	$155.17 - $179.78 $591,042 - $684,782	-3,809 Reduced 4.44%	81,908 $13.8 Million
Q1 2018 May 11, 2018	SELL	$148.01 - $168.91 $16,577 - $18,917	-112 Reduced 0.13%	85,717 $13.8 Million
Q4 2017 Jan 23, 2018	SELL	$143.51 - $159.74 $362,362 - $403,343	-2,525 Reduced 2.86%	85,829 $13.3 Million
Q3 2017 Nov 03, 2017	SELL	$138.36 - $147.87 $204,496 - $218,551	-1,478 Reduced 1.65%	88,354 $12.5 Million
Q2 2017 Aug 11, 2017	BUY	N/A	89,832	89,832 $12.5 Million

Others Institutions Holding SYK

# of Institutions

2,248

Shares Held

283M

Call Options Held

1.35M

Put Options Held

1.61M

View Full List

About STRYKER CORP

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $149B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

More about SYK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Godsey & Gibb Associates, based on Form 13F filings with the SEC.

News

Stay updated on Godsey & Gibb Associates with notifications on news.

Account

Godsey & Gibb Associates Stryker Corp Transaction History